Synamics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 1833, Uxbridge, Ontario, L9P 1N9,...Phone Number
(781) 743-1794Website
www.synamics.comRevenue
<$5 MillionIndustry
About Synamics
Is Synamics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Synamics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Synamics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Synamics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Synamics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Synamics
Check out if Synamics is spiking on competitors!
Product Launch: Get notified when Synamics launches new products
Earning: See what the market has to say on Synamics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Synamics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Synamics
Compare insights from companies similar to Synamics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Synamics
Company Profile Activity
Activity Insights
Synamics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Synamics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Synamics.
Synamics Tech Stack
A closer look at the technologies used by Synamics
Synamics News & Media
Synamics Therapeutics, AI-Driven Drug Discovery Startup, Attracts Former Novozymes Executives as Lead Investors
Copenhagen, Denmark – July 16, 2024 – Synamics Therapeutics, a groundbreaking AI-driven drug discovery startup dedicated to combating drug resistance in cancer, proudly announces a lead investment in its pre-seed round, from two prominent figures in the biotechnology industry. Steen Riisgaard and Per Falholt have backed Synamics Therapeutics as lead investors. Riisgaard, former CEO of Novozymes, member of the Novo Nordisk Foundation’s board, and esteemed biotech investor and Falholt, former Chie
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Synamics
Synamics Therapeutics is a groundbreaking AI-driven drug discovery startup dedicated to combating drug resistance in cancer. The company is based in Denmark.... Read More